|
Arteris, Inc.
Condensed Consolidated Statements of Loss (In thousands, except share and per share data) (Unaudited) |
|||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Revenue | |||||||||||||||
| Licensing, support and maintenance | $ | 13,553 | $ | 12,998 | $ | 25,292 | $ | 24,842 | |||||||
| Variable royalties and other | 1,022 | 1,736 | 2,230 | 3,046 | |||||||||||
| Total revenue | 14,575 | 14,734 | 27,522 | 27,888 | |||||||||||
| Cost of revenue | 1,458 | 1,225 | 2,926 | 2,349 | |||||||||||
| Gross profit | 13,117 | 13,509 | 24,596 | 25,539 | |||||||||||
| Operating expenses: | |||||||||||||||
| Research and development | 10,717 | 12,087 | 21,552 | 23,468 | |||||||||||
| Sales and marketing | 5,013 | 5,601 | 10,469 | 10,606 | |||||||||||
| General and administrative | 4,828 | 4,504 | 9,150 | 8,905 | |||||||||||
| Total operating expenses | 20,558 | 22,192 | 41,171 | 42,979 | |||||||||||
| Loss from operations | (7,441 | ) | (8,683 | ) | (16,575 | ) | (17,440 | ) | |||||||
| Interest expense | (68 | ) | (27 | ) | (144 | ) | (59 | ) | |||||||
| Other income (expense), net | 865 | 835 | 1,801 | 1,743 | |||||||||||
| Loss before income taxes and loss from equity method investment | (6,644 | ) | (7,875 | ) | (14,918 | ) | (15,756 | ) | |||||||
| Loss from equity method investment, net of tax | 725 | 734 | 1,484 | 1,568 | |||||||||||
| Provision for income taxes | 975 | 556 | 1,345 | 851 | |||||||||||
| Net loss | $ | (8,344 | ) | $ | (9,165 | ) | $ | (17,747 | ) | $ | (18,175 | ) | |||
| Net loss per share attributable to common stockholders, basic and diluted | $ | (0.22 | ) | $ | (0.26 | ) | $ | (0.47 | ) | $ | (0.52 | ) | |||
| Weighted average shares used in computing per share amounts, basic and diluted | 38,476,934 | 35,250,157 | 38,092,996 | 34,925,800 | |||||||||||
